Following the validation of nucleolin presence at the cell surface of ovarian cancer cell lines, cellular association studies were performed in order to confirm the potential of F3 peptide-targeted intracellular drug delivery strategy towards ovarian cancer cells, including ovarian CSC. This evidence concerns the gene NUCLEOLIN and ovarian cancer.